Riccardi, Laura
 Distribuzione geografica
Continente #
NA - Nord America 3.724
EU - Europa 2.842
AS - Asia 2.550
SA - Sud America 422
Continente sconosciuto - Info sul continente non disponibili 106
AF - Africa 55
OC - Oceania 7
Totale 9.706
Nazione #
US - Stati Uniti d'America 3.610
SG - Singapore 1.155
DE - Germania 1.083
CN - Cina 595
IT - Italia 429
SE - Svezia 372
BR - Brasile 336
VN - Vietnam 243
FR - Francia 207
GB - Regno Unito 151
UA - Ucraina 129
IE - Irlanda 106
FI - Finlandia 94
IN - India 80
RU - Federazione Russa 75
BD - Bangladesh 72
JP - Giappone 66
ID - Indonesia 64
CA - Canada 61
TR - Turchia 58
HK - Hong Kong 54
PL - Polonia 35
AR - Argentina 32
NL - Olanda 32
MX - Messico 26
IQ - Iraq 24
KR - Corea 20
ES - Italia 19
BE - Belgio 16
EC - Ecuador 16
SA - Arabia Saudita 15
AT - Austria 14
CZ - Repubblica Ceca 13
LT - Lituania 13
PH - Filippine 13
ZA - Sudafrica 13
IR - Iran 12
VE - Venezuela 12
CI - Costa d'Avorio 11
PK - Pakistan 10
TW - Taiwan 10
PE - Perù 9
CH - Svizzera 8
MA - Marocco 8
RO - Romania 8
AU - Australia 7
EU - Europa 7
HN - Honduras 7
IL - Israele 7
KE - Kenya 7
EG - Egitto 6
TT - Trinidad e Tobago 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
CL - Cile 5
KG - Kirghizistan 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
HR - Croazia 4
JM - Giamaica 4
JO - Giordania 4
PA - Panama 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
CY - Cipro 3
KZ - Kazakistan 3
LV - Lettonia 3
NP - Nepal 3
PT - Portogallo 3
TH - Thailandia 3
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
GE - Georgia 2
HU - Ungheria 2
LB - Libano 2
MD - Moldavia 2
MK - Macedonia 2
MY - Malesia 2
NO - Norvegia 2
PY - Paraguay 2
QA - Qatar 2
TN - Tunisia 2
A1 - Anonimo 1
AM - Armenia 1
BB - Barbados 1
BO - Bolivia 1
CG - Congo 1
EE - Estonia 1
KH - Cambogia 1
KM - Comore 1
KW - Kuwait 1
LK - Sri Lanka 1
Totale 9.602
Città #
Singapore 673
Chandler 355
Ashburn 342
San Jose 334
Dallas 262
New York 173
Dublin 104
Los Angeles 104
Beijing 95
Milan 91
Rome 91
Hefei 83
Ho Chi Minh City 74
Munich 70
Nürnberg 68
Jacksonville 67
San Mateo 62
The Dalles 62
Tokyo 62
Hanoi 61
Lauterbourg 60
Jakarta 58
Ann Arbor 48
Helsinki 47
Hong Kong 45
Boston 44
Nanjing 44
Frankfurt am Main 41
Marseille 39
Council Bluffs 38
Bremen 36
Zhengzhou 36
Moscow 35
Boardman 34
São Paulo 33
Izmir 31
Wilmington 31
Buffalo 30
Princeton 29
St Louis 29
Chicago 28
Cattolica 27
Dearborn 27
Kent 27
Warsaw 26
Turku 21
London 20
Seoul 20
Toronto 20
Nanchang 19
Brooklyn 18
Paris 17
Tianjin 17
Atlanta 16
Brussels 16
Woodbridge 16
Denver 15
Orem 15
Santa Clara 15
Seattle 15
Düsseldorf 14
Kunming 14
Nuremberg 14
Redwood City 14
Hebei 13
Phoenix 13
Shanghai 13
Da Nang 12
Lancaster 12
Mexico City 12
Montreal 12
Shenyang 12
Tukwila 12
Abidjan 11
Amsterdam 11
Augusta 11
Leawood 11
Stockholm 11
Baghdad 10
Las Vegas 10
Poplar 10
Pune 10
Ankara 9
Chennai 9
Houston 9
Lawrence 9
Manchester 9
Charlotte 8
Fairfield 8
Florence 8
Hải Dương 8
Jinan 8
Mountain View 8
North Bergen 8
Rio de Janeiro 8
Taipei 8
Belo Horizonte 7
Cambridge 7
Changsha 7
Dhaka 7
Totale 4.823
Nome #
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging 457
Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial 287
A phase II study of sunitinib in advanced hepatocellular carcinoma 280
HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection 244
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 237
Ethanol injection is highly effective for hepatocellular carcinoma smaller than 2 cm 203
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 201
Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis 193
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 193
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 192
Liver transplantation in patients with alcoholic liver disease: A retrospective study 192
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 191
Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study 190
Multiparametric ultrasound for the prediction of the short-term outcome after esophageal varices band ligation 179
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 179
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 179
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 177
A case of non-occlusive mesenteric ischemia and hepatic portal venous gas: not everyone knows that… 175
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 171
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 171
Dynamic Contrast-Enhanced Ultrasound in the Prediction of Advanced Hepatocellular Carcinoma Response to Systemic and Locoregional Therapies 168
Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma 159
Noninvasive Evaluation of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: The Role of Contrast-Enhanced Ultrasound Perfusion Imaging and Elastography 157
Correlation Between QElaXto Techniques and Supersonic Imagine for Liver Stiffness Quantification in Chronic Liver Disease 153
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 150
Severe Skin Burn at Needle Entry Point Complicating Radiofrequency Ablation for Hepatocellular Carcinoma 149
Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes. 149
Dynamics of liver stiffness predicts complications in patients with HCV related cirrhosis treated with direct-acting antivirals 144
Single Hepatocellular Carcinoma Smaller than 2 cm: Are Ethanol Injection and Radiofrequency Ablation Equally Effective? 141
Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial 138
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma 137
Contrast-enhanced power doppler of the intestinal wall in the evaluation of patients with Crohn disease 134
Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment 134
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules 134
The role of elastography in non-Alcoholic fatty liver disease 134
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 132
Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors 127
Correlation between a New Point-Shear Wave Elastography Device (X+pSWE) with Liver Histology and 2D-SWE (SSI) for Liver Stiffness Quantification in Chronic Liver Disease 123
The Gemelli Ultrasound Chronic Pancreatitis Score: A Non-invasive Tool for the Diagnosis of Chronic Pancreatitis 119
Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience 118
Personalized Therapy in a Multidisciplinary Team Improves Survival in Patient with HCC: The Hepatocatt Experience 117
Diffuse liver infiltration by lobular breast carcinoma: Shear wave elastography as gold standard imaging study. 116
Contrast-Enhanced Ultrasound for Monitoring Treatment Response in Different Stages of Hepatocellular Carcinoma 114
Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors 113
Minimal Hepatic Encephalopathy is Associated with Increased Cerebral Vascular Resistance. A Transcranial Doppler Ultrasound Study 113
Prognostic value of liver stiffness in patients hospitalized for acute decompensated heart failure: a meta-analysis 112
Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapy 111
Contrast-Enhanced Imaging in the Management of Intrahepatic Cholangiocarcinoma: State of Art and Future Perspectives 110
Clinical impact of comorbidities in an Italian NAFLD cohort 109
ADAMTS-13/von Willebrand factor ratio: A prognostic biomarker for portal vein thrombosis in compensated cirrhosis. A prospective observational study 109
A new ultrasound score for the assessment and follow-up of chronic pancreatitis: The ‘Gemelli USCP score’ 107
Elastography assessment in patients with chronic HCV infection 106
The Role of Transabdominal Ultrasound Elastography in Gastrointestinal Non-Liver Diseases: Current Application and Future Prospectives 103
Assessing Baveno VI criteria with liver stiffness measured using a new point-shear wave elastography technique (BAVElastPQ study) 102
COMMON CLINICAL COMORBIDITIES IN AN ITALIAN NAFLD COHORT 93
Shear Wave Dispersion in Chronic Liver Disease: From Physical Principles to Clinical Usefulness 91
Treatment of Portal Vein Tumor Thrombosis (PVTT) Can Impact Survival of Patients With Advanced HCC? 88
New Therapeutic Perspectives for Management of Advanced Hepatocellular Carcinoma With Hepatic Arteriovenous Fistula: Balloon-Occluded Percutaneous Radio-Frequency Thermal Ablation (RFA) Plus Transcatheter Arterial Chemoembolization (TACE) 88
Hepatocellular carcinomas <2 cm in diameter complicating cirrhosis: ultrasound and clinical features in 153 consecutive patients 88
Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate 88
Effectiveness of Radiofrequency Ablation of Hepatocellular Carcinoma 87
Multimodal dynamic ultrasound approach as predictor of response in patients with Crohn’s disease treated with ustekinumab 85
Single-Step Balloon-Occluded Percutaneous Radio-Frequency Thermal Ablation (RFA) Plus Transcatheter Arterial Chemoembolization (TACE) for Treatment of "Complex" Unresectable Hepatocellular Carcinoma 84
Dynamic contrast enhanced ultrasound in gastrointestinal diseases: A current trend or an indispensable tool? 75
bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial 65
Performance of Noninvasive Tests for Metabolic Dysfunction-Associated Steatohepatitis and Liver Fibrosis Resolution after Bariatric Surgery 62
Evolution of focal nodular hyperplasia during long-term ultrasound follow-up: results from a single-center study 36
Liver Elastography for Liver Fibrosis Stratification: A Comparison of Three Techniques in a Biopsy-Controlled MASLD Cohort 22
PERSoN4: A multiparametric ultrasound model to improve CEUS LI-RADS for HCC 11
Shear wave elastography in healthy patients: Pancreatic stiffness is less reliable than liver and spleen measurements 7
Multiparametric ultrasound for non-invasive assessment of liver steatosis, fibrosis, and inflammation in metabolic dysfunction-associated steatotic liver disease 3
Totale 9.706
Categoria #
all - tutte 36.872
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.872


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022391 0 27 13 25 31 8 10 69 14 37 64 93
2022/20231.110 140 133 85 184 55 112 71 95 122 28 49 36
2023/2024645 23 141 33 31 30 138 41 24 10 36 57 81
2024/20251.442 36 29 123 70 125 52 52 106 186 130 287 246
2025/20263.822 454 105 418 412 612 173 615 218 283 243 141 148
2026/2027511 130 381 0 0 0 0 0 0 0 0 0 0
Totale 9.706